These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 32922056)

  • 21. Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study.
    Jin Y; Sun X; Zhao X; Zhu T
    Diabetes Ther; 2017 Jun; 8(3):611-621. PubMed ID: 28349442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice.
    Al Mansari A; Obeid Y; Islam N; Fariduddin M; Hassoun A; Djaballah K; Malek M; Dicker D; Chaudhury T
    BMJ Open Diabetes Res Care; 2018; 6(1):e000519. PubMed ID: 30023075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study.
    Curtis B; Lage MJ
    J Med Econ; 2014 Jan; 17(1):21-31. PubMed ID: 24195723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response.
    Gu T; Hong T; Zhang P; Tang S; Bi Y; Lu H; Men L; Ma D; Zhu D
    Diabetes Ther; 2018 Apr; 9(2):771-787. PubMed ID: 29524190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
    Peng XV; McCrimmon RJ; Shepherd L; Boss A; Lubwama R; Dex T; Skolnik N; Ji L; Avogaro A; Blonde L
    Diabetes Ther; 2020 Nov; 11(11):2629-2645. PubMed ID: 32902774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis.
    Ascher-Svanum H; Zagar A; Jiang D; Schuster D; Schmitt H; Dennehy EB; Kendall DM; Raskin J; Heine RJ
    Diabetes Ther; 2015 Sep; 6(3):303-16. PubMed ID: 26159935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes.
    Suzuki K; Mitsuma Y; Sato T; Anraku T; Hatta M
    J Clin Med Res; 2016 Nov; 8(11):805-814. PubMed ID: 27738482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
    Bu S; Zhang X; Zhu H; Shuai Y; Xing X; Yang W;
    Diabetes Ther; 2017 Aug; 8(4):887-898. PubMed ID: 28623551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis.
    Kostev K; Dippel FW; Rathmann W
    Diabetes Metab Syndr Obes; 2015; 8():45-8. PubMed ID: 25609990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delay in starting insulin after failure of other treatments in patients with type 2 diabetes mellitus.
    Zografou I; Strachan M; McKnight J
    Hippokratia; 2014; 18(4):306-9. PubMed ID: 26052195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31).
    Kanatsuka A; Sato Y; Kawai K; Hirao K; Kobayashi M; Kashiwagi A;
    J Diabetes Investig; 2014 Sep; 5(5):539-47. PubMed ID: 25411622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study.
    Kim SS; Kim IJ; Kim YK; Yoon KH; Son HY; Park SW; Sung YA; Baek HS
    Diabetes Metab J; 2015 Dec; 39(6):481-8. PubMed ID: 26616594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
    Kuo S; Yang CT; Wu JS; Ou HT
    Diabetes Obes Metab; 2019 Feb; 21(2):312-320. PubMed ID: 30187666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Act on Threes" Paradigm for Treatment Intensification of Type 2 Diabetes in Managed Care: Results of a Randomized Controlled Study with an Educational Intervention Targeting Improved Glycemic Control.
    Bieszk N; Reynolds SL; Wei W; Davis C; Kamble P; Uribe C
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1028-38. PubMed ID: 27579824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice.
    Lee J; Cho YK; Kim HS; Jung CH; Park JY; Lee WJ
    Diabetes Metab Syndr Obes; 2019; 12():2745-2753. PubMed ID: 31920354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial.
    Yang W; Yang Z; Zhao J; Lu H; Luo T
    Trials; 2016 Sep; 17(1):470. PubMed ID: 27669747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study.
    Romera I; Díaz S; Sicras-Mainar A; López-Simarro F; Dilla T; Artime E; Reviriego J
    Diabetes Ther; 2020 Feb; 11(2):437-451. PubMed ID: 31884573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies.
    Hua KF; Jing BY; Wu YH
    Diabetes Metab Syndr Obes; 2023; 16():1121-1132. PubMed ID: 37122678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.